Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tero Ala-Kokko is active.

Publication


Featured researches published by Tero Ala-Kokko.


Critical Care Medicine | 2009

Long-term outcome and quality-adjusted life years after severe sepsis

Sari Karlsson; Esko Ruokonen; Tero Varpula; Tero Ala-Kokko; Ville Pettilä

Objective: To study long-term mortality, quality of life (QOL), quality-adjusted life years (QALYs), and costs per QALY in an unselected intensive care unit (ICU) patient population with severe sepsis. Design: Prospective observational cohort study. Setting: Twenty-four ICUs in Finland. Patients: A total of 470 adult patients with severe sepsis who were treated in ICUs between November 1, 2004 and February 28, 2005. The QOL before critical illness was assessed in 252 patients and QOL after severe sepsis in 156 patients (58% of the patients surviving in April 30, 2006). Ninety-eight patients responded to both questionnaires. QOL was assessed by a generic EuroQol-5D (EQ-5D) measurement with summary index (EQsum) and visual analogue scale (VAS). Measurements and Main Results: The 2-year mortality after severe sepsis was 44.9% (211 of 470). The median response time for QOL assessment after severe sepsis was 17 months (interquartile range [IQR] 16–18). The median EQsum (75, IQR 56–92) and EQ VAS (66, IQR 50–80) were lower after severe sepsis than age- and sex-adjusted reference values (p < 0.001 and p < 0.001). The decrease between the mean EQsum reference value and that of severe sepsis patients was 12 (95% confidence interval [CI], 9–16). The difference between the mean EQ VAS reference values and the mean EQ VAS was 8 (95% CI, 5–11). The mean calculated QALYs after severe sepsis were 10.9 (95% CI, 9.7–12.1) and the calculated cost for one QALY was only 2139 &OV0556; for all survivors and nonsurvivors. Conclusions: Two-year mortality after severe sepsis was high (44.9%) and the QOL was lower after severe sepsis than before critical illness as assessed by EQ-5D. However, the mean QALYs for the surviving patients were reasonable and the cost for one QALY was reasonably low, which makes intensive care in patients with severe sepsis cost effective.


Acta Anaesthesiologica Scandinavica | 1997

Transfer of clonidine and dexmedetomidine across the isolated perfused human placenta

Tero Ala-Kokko; P. Pienimäki; E. Lampela; A. Hollmén; Olavi Pelkonen; Kirsi Vähäkangas

Background: The placental transfer of the a2 receptor agonist clonidine, earlier used as an adjuvant in obstetric epidural analgesia, was compared with the transfer of the newer and more %‐selective agonist dexmedetomidine.


Acta Anaesthesiologica Scandinavica | 2004

Acute acalculous cholecystitis in critically ill patients

J. Laurila; Hannu Syrjälä; Päivi Laurila; Juha Saarnio; Tero Ala-Kokko

Background:  Acute acalculous cholecystitis (AAC) is a serious complication of critical illness. We evaluated the underlying diseases, clinical and diagnostic features, severity of associated organ failures, and outcome of operatively treated AAC in a mixed ICU patient population.


Critical Care | 2006

Intensive care acquired infection is an independent risk factor for hospital mortality: a prospective cohort study

Pekka Ylipalosaari; Tero Ala-Kokko; Jouko V. Laurila; Pasi Ohtonen; Hannu Syrjälä

IntroductionThe aim of this study was to elucidate the impact of intensive care unit (ICU)-acquired infection on hospital mortality.MethodsPatients with a longer than 48 hour stay in a mixed 10 bed ICU in a tertiary-level teaching hospital were prospectively enrolled between May 2002 and June 2003. Risk factors for hospital mortality were analyzed with a logistic regression model.ResultsOf 335 patients, 80 developed ICU-acquired infection. Among the patients with ICU-acquired infections, hospital mortality was always higher, regardless of whether or not the patients had had infection on admission (infection on admission group (IAG), 35.6% versus 17%, p = 0.008; and no-IAG, 25.7% versus 6.1%, p = 0.023). In IAG (n = 251), hospital stay was also longer in the presence of ICU-acquired infection (median 31 versus 16 days, p < 0.001), whereas in no-IAG (n = 84), hospital stay was almost identical with and without the presence of ICU-acquired infection (18 versus 17 days). In univariate analysis, the significant risk factors for hospital mortality were: Acute Physiology and Chronic Health Evaluation (APACHE) II score >20, sequential organ failure assessment (SOFA) score >8, ICU-acquired infection, age ≥ 65, community-acquired pneumonia, malignancy or immunosuppressive medication, and ICU length of stay >5 days. In multivariate logistic regression analysis, ICU-acquired infection remained an independent risk factor for hospital mortality after adjustment for APACHE II score and age (odds ratio (OR) 4.0 (95% confidence interval (CI): 2.0–7.9)) and SOFA score and age (OR 2.7 (95% CI: 2.9–7.6)).ConclusionICU-acquired infection was an independent risk factor for hospital mortality even after adjustment for the APACHE II or SOFA scores and age.


Acta Anaesthesiologica Scandinavica | 2000

Two instances of central nervous system toxicity in the same patient following repeated ropivacaine-induced brachial plexus block

Tero Ala-Kokko; A. Löppönen; S. Alahuhta

We describe two instances of central nervous system (CNS) toxicity in the same patient following repeated brachial plexus blocks induced by high doses of ropivacaine (6 mg · kg−1 and 4.5 mg · kg−1, respectively). Although very high total and free plasma concentrations of ropivacaine were found up to 98 min after induction of the blocks, no signs of cardiovascular toxicity apart from hypertension and sinus tachycardia were observed. The measured plasma concentrations are the highest so far reported in the literature. We conclude that this case demonstrates the high cardiovascular safety level of ropivacaine. These high doses, however, resulted in severe toxic CNS symptoms. Therefore, it is stressed that the dose in relation to the weight of the patient must be calculated when administering a large volume of local anesthetic.


Resuscitation | 2009

Incidence of iatrogenic dyscarbia during mild therapeutic hypothermia after successful resuscitation from out-of-hospital cardiac arrest.

Patrik Falkenbach; Antti Kämäräinen; Antti Mäkelä; Jouni Kurola; Tero Varpula; Tero Ala-Kokko; Juha Perttilä; Jyrki Tenhunen

To investigate the incidence of iatrogenic dyscarbia in survivors of out-of-hospital cardiac arrest treated with induced mild hypothermia.We performed a retrospective cohort study of the ventilatory management based on blood gas analyses of patients resuscitated from prehospital cardiac arrest. In the pilot phase, we assessed the ventilatory management in the patients treated in one university hospital during a 4-year study period. Subsequently, a more recent (1-year) retrospective cohort of resuscitated patients from all five Finnish university hospitals concerning the first 48h after hospital admission was analyzed. Core temperatures and temperature corrected (or non-corrected) blood gas analysis results with focus on carbon dioxide tension were analyzed. In addition, a survey was performed to investigate the ventilatory strategies in all Finnish hospitals providing mild hypothermia for cardiac arrest victims.The pilot cohort suggested a high incidence of hypo- or hyper-carbia during hypothermia treatment. In the multicenter patient population of 122 patients contributing a total of 1627 measurements, the PaCO(2) distribution was as follows: less than 4 kPa in 148 samples out of 1627 (9%), 4-4.6 kPa in 404 (25%), 4.7-6 kPa in 887 (55%) and more than 6 kPa in 188 samples (12%). There was a significant difference in the incidence of hypercarbia between the hospitals (p<0.05).We conclude that normocarbia was achieved/maintained only in approximately 55% of the samples. The incidence of hypo- or hyper-carbia (dyscarbia) was high (45%). This may predispose for serious derangements in the cerebral perfusion of the resuscitated patient. These results call for vigilance in adjustment of the ventilatory management to meet the needs of the patients treated with mild hypothermia.


Acta Anaesthesiologica Scandinavica | 2006

Anti-inflammatory effect of high-dose insulin treatment after urgent coronary revascularization surgery.

J. K. Koskenkari; P. Kaukoranta; Jussi Rimpiläinen; V. Vainionpää; Pasi Ohtonen; Heljä-Marja Surcel; Tatu Juvonen; Tero Ala-Kokko

Background:  The administration of insulin has been shown to exert cardioprotective and immunomodulatory properties. Ischemia and inflammation are typical features of acute coronary syndrome, thus it was hypothesized that high‐dose glucose–insulin–potassium (GIK) treatment could suppress the systemic inflammatory reaction and attenuate myocardial ischemia–reperfusion injury in patients with unstable angina pectoris after urgent coronary artery bypass surgery.


Critical Care | 2010

Variations in the length of stay of intensive care unit nonsurvivors in three scandinavian countries

Kristian Strand; Sten Walther; Matti Reinikainen; Tero Ala-Kokko; T Nolin; Jan Martner; Petteri Mussalo; Eldar Søreide; Hans Flaatten

IntroductionThe length of stay (LOS) in intensive care unit (ICU) nonsurvivors is not often reported, but represents an important indicator of the use of resources. LOS in ICU nonsurvivors may also be a marker of cultural and organizational differences between units. In this study based on the national intensive care registries in Finland, Sweden, and Norway, we aimed to report intensive care mortality and to document resource use as measured by LOS in ICU nonsurvivors.MethodsRegistry data from 53,305 ICU patients in 2006 were merged into a single database. ICU nonsurvivors were analyzed with regard to LOS within subgroups by univariate and multivariate analysis (Cox proportional hazards regression).ResultsVital status at ICU discharge was available for 52,255 patients. Overall ICU mortality was 9.1%. Median LOS of the nonsurvivors was 1.3 days in Finland and Sweden, and 1.9 days in Norway. The shortest LOS of the nonsurvivors was found in patients older than 80 years, emergency medical admissions, and the patients with the highest severity of illness. Multivariate analysis confirmed the longer LOS in Norway when corrected for age group, admission category, sex, and type of hospital. LOS in nonsurvivors was found to be inversely related to the severity of illness, as measured by APACHE II and SAPS II.ConclusionsDespite cultural, religious, and educational similarities, significant variations occur in the LOS of ICU nonsurvivors among Finland, Norway, and Sweden. Overall, ICU mortality is low in the Scandinavian countries.


Resuscitation | 2003

Aspiration pneumonia following severe self-poisoning

Janne H. Liisanantti; Päivi Kaukoranta; Matti Martikainen; Tero Ala-Kokko

PURPOSE To investigate the risk factors of aspiration pneumonia following severe self-poisoning. MATERIALS AND METHODS Patients treated due to severe self-poisoning in the ICU of Oulu University Hospital, Oulu, Finland during 1.11.1989-31.10.2000 were analyzed retrospectively. RESULTS 28.4% of 257 patients fulfilled the criteria of aspiration pneumonia. An unconscious patient who was not intubated until arrival at the emergency room (ER) had an odds ratio (OR) of 3.34 (CI 1.3-8.7) for aspiration pneumonia. If the patient was intubated at the first contact with health care providers, OR was 1.8 (CI 0.6-5.7). The use of gastric lavage or activated charcoal in the case of a non-intubated unconscious patient led to ORs of 2.7 (CI 0.8-9.3) and 3.7 (CI 1.01-12.5), respectively. The mean length of ICU stay was 0.9 (CI 0.8-0.9) days among patients without aspiration pneumonia and 1.9 (CI 1.3-2.6) days among those with aspiration pneumonia. The mean length of hospital stay was 2.8 (CI 2.5-3.1) days among the patients without aspiration pneumonia and 6.5 (CI 5.3-7.6) days among those with aspiration pneumonia. CONCLUSION To avoid aspiration pneumonia intubation of an unconscious patient on scene before arrival at the ER is recommended. The use of gastric lavage and activated charcoal increase the risk of aspiration pneumonia if the patient is unconscious and not intubated. Aspiration pneumonia significantly prolongs the length of ICU and hospital stay.


Acta Anaesthesiologica Scandinavica | 2000

Pharmacokinetics of 0.2% ropivacaine and 0.2% bupivacaine following caudal blocks in children.

Tero Ala-Kokko; A. Partanen; J. Karinen; Kai Kiviluoma; S. Alahuhta

Background: Ropivacaine is the first S‐enantiomer aminoamide local anaesthetic in clinical use, and has been found to be less toxic than bupivacaine. Caudal ropivacine has been shown to cause less motor blockade and longer duration of analgesia in the postoperative period than bupivacaine in children. Plasma levels of ropivacaine and bupivacaine have not been previously compared in children. This study was undertaken to compare the total venous plasma concentrations of similar doses of ropivacaine and bupivacaine following caudal administration.

Collaboration


Dive into the Tero Ala-Kokko's collaboration.

Top Co-Authors

Avatar

Pasi Ohtonen

Oulu University Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

J. Laurila

Oulu University Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Juha Saarnio

Oulu University Hospital

View shared research outputs
Top Co-Authors

Avatar

Matti Reinikainen

University of Eastern Finland

View shared research outputs
Top Co-Authors

Avatar

S. Alahuhta

Oulu University Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge